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Vascular allografts were first used in humans to replace the diseased aorta [I]. 
Although short term results were good. most of these grafts eventually deteriorated 
as a consequence of immunologic injury. 
Vascular allografts. however. have continued to be used in organ transplantation. 
Kidneys with injured or multiple renal arteries can often be reconstructed and 
successfully implanted with the use of an auxiliary arterial allograft. Furthermore. 
the right renal vein is often too short to allow implantation of a kidney without 
excessive tension. In this instance. vein grafts can be used to lengthen the renal vein. 
We herein report our experience with 149 consecutive renal transplants. The 
incidence and indications for the use of auxiliary arterial or venous grafts and a 
comparison of outcome with transplants not requiring the use of such grafts is 
reviewed. 
MATERIALS AND METHODS 
We reviewed 149 consecutive non-matched cadaveric renal transplants in 142 
patients performed on the general surgical service at the University Health Center 
of Pittsburgh from June 1984 to July 1986. There were 142 primary grafts. 6 
secondary grafts. and 1 tertiary graft. Follow-up extended through December 1986. 
there were 92 (64.8%) male and 50 (35.2%) female recipients with ages ranging 
from 2 to 66 years (mean 39.2 ~ 14.5. S.D.). All patients were treated with 
combination immunosuppression with cyclosporine-prednisone as previously 
described [2]. Since November 1984. we have used OKT3 monoclonal antibody 
(Orthoclone OKT3. Ortho Pharmaceutical;" Raritan. NJ) for the treatment of steroid-
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Harvesting of Iliac Grafts 
Figure 19.1. Harvest and 
division of donor iliac 
arteries. 
resistant acute cellular rejection. A small number of patients with severe rejection or 
cyclosporine intolerance were also treated with low dose azathioprine. 
Vascular grafts including the aortoiliac vessels and the ilioca\'al veins were 
procured immediately after completing the cadaver donor nephrectomy and were 
stored in Terasaki medium at 4·C (Figure 19.1). Grafts were discarded if not used 
within I week of harvest. Whenever possible. grafts from the same donor as the renal 
allograft were used. but if these were not available. ABO blood group matched grafts 
were used. 
Short renal veins were reconstructed with direct extensions of allograft vena cava 
or interposition iliac vein grafts (Figures 19.2 and 19.3). Repair of an arterial injury 
is sho"n in Figure 19.4. Arterial grafts were also occasionally required because of 
atherosclerosis. En-bloc pediatric renal grafts were implanted on a stalk of aorta and 
vena cava as previously described [3]. 
Statistical analysis (chi-square. t-test. and life table survival anal:- sis) was per-
formed on an IBM:PC-AT microcomputer using SPSS. PC+ (SPSS. Inc .. Chicago. 
IL) and BMDP (BMDP Statistical Software. Los Angeles. CA). 
Donor Iliac 
Vein Graft 
Figure 19.2. Lengthening of a 
Donor Vena Cava 
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short fight renal vein by direct Figure 19.3. Lengthening of a short right renal vein by 
extension of the vena cava. use of an auxiliary interpOsition iliac vein graft. 
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Repair of Donor Figure 19.4 Repair of harvesling injUry to the 
Renal Artery renal artery using an auxiliary interpOsition 
Harvesting Injury arterial graft 
RESULTS 
Patient sUr\·i,·al. If the 142 patients. 131 (92.3CC) are living and 11 (7.7%) are 
dead. There is no difference in the mean age of patients who required an auxiliary 
vascular graft (3R.7 :: 13.9. S.D. years) and those who did not (40.2 :: 16.0. S.D. 
years). Actuarial survival at one year for the 101 patients who did not require an 
auxiliary vascular graft is 92. 7'c and for the 41 patients requiring a \enous or anerial 
graft is 94.3'( (p=NS. Figure 19.5A). 
RCI/a/ fUl/ctiol/ al/d graft sun·im/. Of the renal transplants. 104 (fJ9's,() are still 
functioning. including 72 (07.3,() done without an auxiliary va~cular graft and 32 
(70.2,() done with such a graft (Table 19.1). Actuarial survival at one year for the 
107 renal transplant~ not requiring an auxiliary \ascular graft is fJlJY; and for the 
42 renal transplants requiring a venous or arterial graft is 75A,( (p=NS. Figure 
19.5B). There is no significant difference between mean serum creatinine for 
functioning transplants without a vascular graft (2.5:: 1.5. S.D. mg'dl) and function-
ing transplants with a vascular graft (2.2 ± D.l, S.D. mgJdl). 
H?/IoUS rCCOl/structions. Venous grafts. including 19 vena caval extensions and II 
iliac vein interposition grafts. were used in 30 (20.2,() cases. Of these grafts. 27 are 
still functioning. 2 were lost to reject.ion. and 1 to death of the patient. None have 
been lost to thrombosis. 
Arterial rccolISt/'//ctiol/s. Arterial allugrafts were used in 5 (3.4'() cases to salvage 
harvesting injuries. All of these grafts are still functioning. 
Ell-bloc pediatric grafts ill adults. Seven en-bloc transplants of pediatric renal 
allografts into adult patients were performed. One graft was lost to venous throm-
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Figure 19.5. Actuarial patient survival (Al and actuarial graft survival (8) for renal 
transplants which required or did not require use of an aUXiliary vascular graft (AVG). Use 
of an AVG had no significant effect on either patient or graft survival. 
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bosis. probably as a result of improper positioning of the graft at surgery. One patient 
died with a functioning graft. 
DISCUSSION 
Vascular homografts were first performed in animals in 1896 [4]. Homograft 
banking techniques were developed in the 1940s and have improved since. The 
major complications associated with use of vascular homografts are thrombosis and 
dissection of small vessels and calcification and rupture of larger vessels [5]. 
A classical study by Szilagyi in 1957 on the outcome of 150 homografts found 
that patency was directly proportional to the diameter of the graft [6]. But it was not 
until 1975 that Williams showed that early graft occlusion was, in fact, due to 
immunological rejection. Williams demonstrated that under immunosuppressive 
therapy, graft durability was enhanced and graft endothelium was replaced by host 
endothelium [7). 
It is now believed that vascular endothelium may be the antigen- contributing 
component that activates the T-cell in an Ia- restricted manner [8). An alternative 
theory suggests that immunization is initiated by la positive passenger leukocytes. 
The T-helper cells recognize HLA-OR antigen and the graft undergoes acute 
rejection [9]. 
Cyclosporine. which has been in use by some transplant centers since 1978, 
suppresses T -helper cell function and also has a variety of other immunosuppressive 
effects (10-12]. In this report, we have presented a favorable experience with the use 
of auxiliary vascular grafts in a series of renal transplants performed with 
cyclosporine and prednisone immunosuppression. We found no evidence that the 
use of such grafts affects transplant function or graft outcome. The continuing excess 
demand for cadaveric organs for transplantation mandates that every effort be made 
to salvage all available organs. The use of auxiliary vascular allografts is an 
important method for salvage of vascular injuries and other complications that 
contribute to unnecessary organ wastage. 
Excessive tension on the short right renal vein is the most frequent cause of renal 
vein thrombosis after transplantation in our experience. If the vena cava has been 
prcservcd in continuity with the right renal vein at harvest. a direct extension of the 
vcna cava is a simple way to lengthen it; otherwise, an intcrposition vein graft is 
necessary. We have not experienced any cases of renal vein thrombosis in grafts 
with renal veins extended by either of these methods. 
Pediatric kidneys are frequently wasted for lack of a suitable pediatric recipient 
and because many transplant surgeons are reluctant to put very small kidneys into 
adults. The use of an en-bloc pair of pediatric kidneys on a stalk of aorta and vena 
cava is one method for implanting a larger renal mass into adults using pediatric 
kidneys. This method. however. requires two ureteral implants and careful position-
ing of the complex graft to avoid vascular thrombosis. Our experience with these 
grafts has been favorable. and we continue to use them when possible. 
The follow-up for this series has been 6 months to 2 years. No graft aneurysms 
or infections have yet been encountered. Additional follow-up will be necessary to 
.j 
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determine the long-term fate of many of these grafts. Doppler ultrasound is currently 
in use to monitor now in the grafts and to screen for other complications. 
SUMMARY 
A series of 149 consecutive, non-matched cadaveric renal transplants in 142 
patients was reviewed. Auxiliary arterial or venous grafts were used in 42 cases. 
There was no difference in patient or graft survival or in the quality of graft function 
between transplants with and without auxiliary grafts. No arterial auxiliary grafts or 
renal vein extensions were lost to thrombosis. One en-bloc pair of pediatric kidneys 
was lost to venous thrombosis, probably because of malposition at implantation. 
There were no graft aneurysms or infections. The use of auxiliary vascular allografts 
is a safe and effective method for salvaging renal grafts that might otherwise be 
wasted. 
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